- Company — Mindstrong Health
- Sector — Digital mental health
- Founded / Died — 2014 / February–March 2023
- Lifespan — ~9 years
- Capital raised — ~$160M (ARCH Venture Partners, Foresite Capital, General Catalyst, Optum Ventures)
- Peak scale — ~130 employees at HQ before closure; patient volumes modest and never fully disclosed; peak valuation not publicly confirmed.
- What it built — Originally a "digital biomarker" platform claiming that smartphone typing and swipe patterns could predict mental-health deterioration — a "smoke alarm for mental illness" — later pivoted to a virtual mental-health clinic.
- Stated cause of death — The company said it was winding down and selling its technology; co-founder statements emphasised a difficult funding environment and the challenge of building a care-delivery business.
- Evidenced cause — Substantial divergence, well documented by STAT News. Reporting established that the central scientific claim — that passive smartphone signals reliably predicted psychiatric events — did not hold up in practice, that internal validation was weaker than the external positioning implied, and that the pivot to conventional virtual care put Mindstrong into direct competition with better-funded, better-distributed telehealth companies with none of its differentiation. The stated "funding environment" cause is true but downstream of a failed core hypothesis.
- Warning signs visible earlier — The digital-biomarker claim was contested by academic psychiatrists from at least 2019. The 2021–22 pivot to clinic services was itself the admission.
- Money outcome — Investors lost most of ~$160M. 128 employees laid off; technology acquired by SonderMind for an undisclosed (small) sum.
- Post-mortem quality — Poor from the company; excellent from journalism (STAT's multi-part investigation). Another case where the durable document is a reporter's.
- Transferable lesson — When a company's differentiation is a scientific claim, the claim must be validated on the same schedule as the fundraising.
- Sources — STAT News investigation · STAT on Mindstrong and Pear · MedTech Dive
Read the wider evidence
This entry is reproduced from the supplied research, with its inline source links retained. It has not been independently re-reported for this website conversion.
Read the complete chapter, source list, and methodological notes →